Sign in

CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company

Humacyte, Inc.

Sign in to watch
Ticker
HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851763759
Phone
919-313-9633
Business address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
Former names
Alpha Healthcare Acquisition Corp.
Open-market buys, last 90 days
$30,370
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Jones Keith Anthony +$30K Director 3 filings
Date Insider Transaction Shares Price Value Owned after
2021-08-26 Sander Dale A. CFO and Chief Corp. Deve. Off. Grant or award · Stock Options (right to buy) +1,575 1,575
2021-08-26 Sander Dale A. CFO and Chief Corp. Deve. Off. Grant or award · Stock Options (right to buy) +183,817 183,817
2021-08-26 Sander Dale A. CFO and Chief Corp. Deve. Off. Grant or award · Stock Options (right to buy) +210,077 210,077
2021-08-26 Tente William Edward Chief Regulatory Officer Grant or award +52,519 52,519
2021-08-26 Tente William Edward Chief Regulatory Officer Grant or award · Stock Options (right to buy) +6,564 6,564
2021-08-26 Tente William Edward Chief Regulatory Officer Grant or award · Stock Options (right to buy) +91,908 91,908
2021-08-26 Tente William Edward Chief Regulatory Officer Grant or award · Stock Options (right to buy) +91,908 91,908
2021-08-26 Tente William Edward Chief Regulatory Officer Grant or award · Stock Options (right to buy) +118,168 118,168
2021-08-26 Tente William Edward Chief Regulatory Officer Grant or award · Stock Options (right to buy) +1,575 1,575
2020-09-22 Shukla Rajiv Chief Executive Officer Other acquisition +305,000 $10.00 $3.0M 305,000

Page 17 of 17 · 330 trades